Spermosens AB (FRA:9R5) Accounts Payable: €0.04 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Spermosens AB Accounts Payable?

Spermosens AB FRA:9R5 Accounts Payable is €0.04 Mil as of Mar. 2026.

Spermosens AB's Accounts Payable for the quarter that ended in Mar. 2026 was €0.04 Mil.

Spermosens AB's quarterly Accounts Payable declined from Sep. 2025 (€0.01 Mil) to Dec. 2025 (€0.01 Mil) but then increased from Dec. 2025 (€0.01 Mil) to Mar. 2026 (€0.04 Mil).

Spermosens AB's annual Accounts Payable increased from Dec. 2023 (€0.12 Mil) to Dec. 2024 (€0.18 Mil) but then declined from Dec. 2024 (€0.18 Mil) to Dec. 2025 (€0.01 Mil).

Spermosens AB Accounts Payable Related Terms

Spermosens AB Accounts Payable Historical Data

* Premium members only.

The historical data trend for Spermosens AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spermosens AB Accounts Payable Chart

Spermosens AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 0.05 0.07 0.12 0.18 0.01

Spermosens AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.03 0.01 0.01 0.04

Spermosens AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €0.04 Mil mean?
Spermosens AB (FRA:9R5) has a Accounts Payable of €0.04 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Spermosens AB and its competitors.
Is Spermosens AB's Accounts Payable too high?
Spermosens AB's current Accounts Payable is €0.04 Mil.
How does Spermosens AB's Accounts Payable compare to TMO and DHR?
Spermosens AB's Accounts Payable of €0.04 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Diagnostics & Research company?
A good Accounts Payable depends on the Medical Diagnostics & Research industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Spermosens AB and its competitors. Spermosens AB's current Accounts Payable is €0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spermosens AB stock overvalued right now?
Spermosens AB (FRA:9R5) has a current Accounts Payable of €0.04 Mil. The current Accounts Payable is €0.04 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Spermosens AB (FRA:9R5), the current Accounts Payable is €0.04 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Spermosens AB Business Description

Other Exchanges SPERM:Sweden
Address Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Spermosens AB is developing a revolutionary platform technology for diagnosing male-factor infertility and directing to the right infertility treatment. It is a developer of medical device products for male infertility, individualizing In Vitro Fertilization (IVF) diagnostics and treatment creating a new standard for faster and safer IVF treatments.